In the BioHarmony Drug Report Database
Levobunolol
Betagan (levobunolol) is a small molecule pharmaceutical. Levobunolol was first approved as Betagan on 1985-12-19. It is used to treat open-angle glaucoma in the USA. The pharmaceutical is active against beta-3 adrenergic receptor, beta-2 adrenergic receptor, and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor.
Trade Name
|
Betagan |
|---|---|
Common Name
|
levobunolol |
ChEMBL ID
|
CHEMBL1201237 |
Indication
|
open-angle glaucoma |
Drug Class
|
Beta-blockers (propranolol type) |
Image (chem structure or protein)